Group 1: Wearables and IPOs - Meta Platforms (META) is set to unveil new smart glasses named "Celeste" with a built-in display at a retail price of $800 [1] - StubHub (STUB) is going public today after several delays, pricing its shares amid a recovering IPO market in 2025 [1] Group 2: Manufacturing Investments - GSK (GSK) announced a $30 billion investment in R&D and manufacturing in the United States [2] - Eli Lilly (LLY) revealed plans for a new $5 billion production plant in Virginia [2] Group 3: Federal Reserve Insights - Danielle DiMartino Booth discussed significant changes at the Federal Reserve, highlighting the impact of easy credit on consumer spending [2] - The conversation noted the reality of stagflation at the company level, with a margin squeeze being observed [2] Group 4: Retail and Media Developments - Kroger (KR) is reintroducing paper coupons as part of its retail strategy [3] - Paramount Skydance's bid for Warner Bros. (WBD) may take longer than expected [3] - Apollo Global (APO) is exploring the sale of AOL, an internet pioneer [4] Group 5: Technology and Transportation - Baidu (BIDU) shares surged as investors anticipate growth in AI [4] - Waymo is set to test robotaxis at San Francisco International Airport [5] Group 6: Market Updates - In Asia, Japan's market decreased by 0.3%, while Hong Kong increased by 1.8% [6] - In Europe, London saw a slight increase of 0.2%, while Paris decreased by 0.1% [6] - Futures indicate a slight increase in Dow by 0.1%, with S&P flat and Nasdaq down by 0.1% [6]

Jim Cramer is a high-profile market commentator on CNBC’s “Mad Money,” known for making bold stock calls. During segments like the “Lightning Round,” where he makes rapid-fire calls based on recent earnings, partnerships, and risks, Cramer explicitly recommended selling Chime (CHYM) stock and buying Affirm Holdings (AFRM) stock instead. Chime is a neobank, or a fintech company, which provides banking services but does not operate like a typical bank. Meanwhile, Affirm Holdings, a fintech, focuses on “buy ...

Winnipeg, Manitoba--(Newsfile Corp. - September 17, 2025) - Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) ("Snow Lake"), a uranium exploration and development company, announces excellent initial drill results on its Pine Ridge Uranium Project ("Pine Ridge"), located in the prolific Powder River Basin in Wyoming, a 50/50 joint venture (the "Joint Venture") with Global Uranium and Enrichment Limited ("GUE").The Joint Venture has completed a total of 33 holes on Pine Ridge, for a total of 1 ...

NEW HARTFORD, N.Y.--(BUSINESS WIRE)--PAR Technology Corporation (NYSE: PAR), a leading foodservice technology provider, today announced the launch of PAR Gamesâ"¢, an interactive loyalty experience designed to engage guests through fun, personalized brand moments triggered by everyday behaviors. By transforming passive loyalty into real-time, emotional engagement, PAR Games helps marketers drive visits, capture zero-party data, and reward guests—without over-relying on discounts. Loyalty programs. ...

Peer-reviewed publication highlights potential breakthrough anti-fibrotic properties of LTI-03 in lung tissue from IPF patientsAUSTIN, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced the publication of novel data on its lead drug candidate, LTI-03, in iScience, a peer-reviewed, open-acc ...

Many homeowners go to great lengths to lower their property tax bills — from setting up trusts to exploiting niche legal loopholes. While these strategies can certainly be effective, they’re often complex and costly. Fortunately, there’s a much simpler way to reduce your property tax burden — stay in your home longer. In many areas, long-term homeowners can benefit from exemptions and assessment caps that limit how quickly their property taxes can increase, even as their home values rise. If you’re comfo ...

Accessibility StatementSkip Navigation VANCOUVER, BC, Sept. 17, 2025 /PRNewswire/ - BTQ Technologies Corp. (the "Company" or "BTQ") ("BTQ" or the "Company") (CBOE CA: BTQ) (FSE: NG3) (OTCQX: BTQQF), a global quantum technology company focused on securing mission-critical networks, is pleased to announce peer-reviewed research result with Macquarie University published in Physical Review Research. The collaboration shows a practical way to perform quantum error correction on high-performing quantum low dens ...

Roofing Corp of America Acquires Florida-Based Springer-Peterson and California-Based A-1 All AmericanTORONTO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that its subsidiary, Roofing Corp of America (“RCA”), has acquired Springer-Peterson Roofing & Sheet Metal (“Springer-Peterson”) and A-1 All American Roofing Co. (“A-1 All American”). These two tuck-under acquisitions further enhance RCA’s presence in key markets within the U.S. Sun Be ...

TORONTO, ON / ACCESS Newswire / September 17, 2025 / Eskay Mining Corp. ("Eskay" or the "Company") (TSXV:ESK)(OTC PINK:ESKYF)(Frankfurt:KN7)(WKN: A0YDPM) is pleased to provide initial assay results from its prospecting and sampling program at its 100%-controlled Consolidated Eskay Project in the Golden Triangle, British Columbia. The Company's geological team, through systematic prospecting and sampling, has significantly expanded the area where high-grade gold veins were discovered in 2024. ...

AUSTIN, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced the publication of novel data on its lead drug candidate, LTI-03, in iScience, a peer-reviewed, open-access journal published by Cell Press. The paper, titled “LTI-03 peptide demonstrates anti-fibrotic activity in ex vivo lung slic ...